로딩 중…
지수 로딩 중…
Tarsus Pharmaceuticals, Inc.
TARS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$63.16+0.98%
2026-06-18
Price Chart
Tarsus Pharmaceuticals, Inc.+53.79%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.72B |
| Revenue | $535M |
| Net Income | $-48M |
| Total Assets | $581M |
| Net Assets | $349M |
| Value | |
| P/B | 7.79x |
| P/S | 5.08x |
| FCF Yield | -1.16% |
| Profitability | |
| ROE | -13.83% |
| ROA | -8.31% |
| Op. Margin | -9.50% |
| Revenue Growth | 106.87% |
| Financial Health | |
| Debt Ratio | 66.54% |
| Total Debt | $89M |
| FCF | $-32M |
| Cash | $102M |
| Current Ratio | 3.74x |
| Performance | |
| 1Y Return | 53.79% |
| 1M Return | 3.05% |
| From 52W High | -25.91% |
| 1Y MDD | -30.42% |
| Trading | |
| Volume | 375,594 shares |
| Trading Value | $24M |
| Per Share | |
| EPS | $-1.55 |
| BPS | $8.03 |